Archives for September 16, 2007

← 2007

Soma 250mg dose gets approval

By  Katrina Megget

Swedish speciality pharma company Meda AB has announced its new low dose of Soma (carisoprodol) has been approved by the US Food and Drugs Administration (FDA).

Bayer, Novartis settle Betaseron battle

By  Anna Lewcock

Novartis and Bayer Schering Pharma have finally settled their disputes over multiple sclerosis (MS) drug Betaseron (interferon beta-1b), with an agreement outlined in March now complete.